We are live on ! Find out more
FA

FDx Advisors Portfolio holdings

AUM $313M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+18.92%
3 Year Est. Return
+56.32%
5 Year Est. Return
+58.97%
10 Year Est. Return
+208.95%
AUM
$2.3B
AUM Growth
+$69.2M
Cap. Flow
-$72.3M
Cap. Flow %
-3.14%
Top 10 Hldgs %
22.72%
Holding
800
New
74
Increased
274
Reduced
386
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Healthcare 12.72%
3 Financials 9.9%
4 Consumer Discretionary 7.79%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
176
State Street SPDR S&P 500 ETF Trust
SPY
$791B
$2.43M 0.11%
6,353
+1,525
+32% +$586K
DE icon
177
Deere & Co
DE
$160B
$2.43M 0.11%
5,660
+168
+3% +$68.3K
WFC icon
178
Wells Fargo
WFC
$262B
$2.42M 0.11%
58,557
-6,583
-10% -$291K
MMM icon
179
3M
MMM
$91.3B
$2.39M 0.1%
23,834
+42
+0.2% +$4.28K
VO icon
180
Vanguard Morningstar Mid-Cap ETF
VO
$107B
$2.34M 0.1%
45,864
+4,948
+12% +$252K
USHY icon
181
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.3B
$2.33M 0.1%
67,457
+3,679
+6% +$127K
IWM icon
182
iShares Russell 2000 ETF
IWM
$79.9B
$2.28M 0.1%
13,073
+347
+3% +$61.7K
DIS icon
183
Walt Disney
DIS
$167B
$2.23M 0.1%
25,645
-1,693
-6% -$162K
FERG icon
184
Ferguson
FERG
$45.5B
$2.21M 0.1%
17,409
+10,055
+137% +$1.17M
DOC icon
185
Healthpeak Properties
DOC
$15.1B
$2.21M 0.1%
88,093
+1,249
+1% +$30.4K
VICI icon
186
VICI Properties
VICI
$29B
$2.2M 0.1%
67,765
+807
+1% +$25.9K
ENB icon
187
Enbridge
ENB
$119B
$2.17M 0.09%
55,600
+4,586
+9% +$179K
SPGI icon
188
S&P Global
SPGI
$122B
$2.12M 0.09%
6,323
-108
-2% -$35.6K
CP icon
189
Canadian Pacific Kansas City
CP
$78.2B
$2.08M 0.09%
27,931
-4,844
-15% -$364K
CRL icon
190
Charles River Laboratories
CRL
$11.2B
$2.08M 0.09%
9,531
-1,934
-17% -$422K
VRTX icon
191
Vertex Pharmaceuticals
VRTX
$121B
$2.08M 0.09%
7,187
-1,107
-13% -$337K
SCZ icon
192
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$2.07M 0.09%
36,654
-4,801
-12% -$258K
ICLR icon
193
Icon
ICLR
$12.7B
$2.07M 0.09%
10,641
-1,540
-13% -$305K
MET icon
194
MetLife
MET
$61.9B
$2.05M 0.09%
28,373
+14,544
+105% +$1.04M
DOW icon
195
Dow Inc
DOW
$21.9B
$2M 0.09%
39,780
+663
+2% +$32.4K
JEPQ icon
196
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$39.4B
$2M 0.09%
48,913
+21,954
+81% +$933K
ICE icon
197
Intercontinental Exchange
ICE
$85.8B
$1.99M 0.09%
19,379
-1,742
-8% -$173K
VTIP icon
198
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$1.98M 0.09%
42,357
-2,881
-6% -$137K
INTU icon
199
Intuit
INTU
$86.4B
$1.96M 0.09%
5,025
+2,445
+95% +$970K
XLK icon
200
State Street Technology Select Sector SPDR ETF
XLK
$115B
$1.95M 0.08%
31,292
-51,480
-62% -$3.27M

Similar funds

FDx Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, FDx Advisors held 800 positions worth $2.3B, up 3.1% from $2.23B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

FDx Advisors withdrew a net $72.3M in Q4 2022, closing 60 positions and reducing 386 holdings. Its most notable exit was iShares Currency Hedged MSCI ACWI ex US ETF, an estimated $4.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, FDx Advisors opened a new position in iShares MSCI ACWI ex US ETF worth $4.25M.

  • FDx Advisors's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 93,392 shares worth $4.25M.
  • FDx Advisors added most to Thermo Fisher Scientific in Q4 2022, an estimated $22.9M increase.
  • FDx Advisors's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $32.7M.
  • FDx Advisors fully exited iShares Currency Hedged MSCI ACWI ex US ETF in Q4 2022, selling an estimated $4.64M.
  • FDx Advisors's ten largest holdings make up 23% of its $2.3B portfolio in Q4 2022.
  • FDx Advisors opened 74 new positions and closed 60 in Q4 2022.
  • FDx Advisors's portfolio value rose 3.1% quarter-over-quarter to $2.3B.

Based on FDx Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.